Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. [electronic resource]
Producer: 20181105Description: 246-255 p. digitalISSN:- 1538-7445
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Benzocycloheptenes -- administration & dosage
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cell Line, Tumor
- Deoxycytidine -- administration & dosage
- Female
- Humans
- Male
- Mice, Inbred C57BL
- Mice, Transgenic
- Molecular Targeted Therapy
- Pancreatic Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Triazoles -- administration & dosage
- Xenograft Model Antitumor Assays
- Gemcitabine
- Axl Receptor Tyrosine Kinase
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.